LexaGene Holdings Inc. (CVE:LXG – Get Free Report) shares fell 19.2% during mid-day trading on Wednesday . The company traded as low as C$0.10 and last traded at C$0.11. 2,135,377 shares traded hands during mid-day trading, an increase of 1,156% from the average session volume of 170,061 shares. The stock had previously closed at C$0.13.
LexaGene Stock Performance
The firm has a fifty day moving average price of C$0.11 and a 200 day moving average price of C$0.11. The company has a current ratio of 1.39, a quick ratio of 1.13 and a debt-to-equity ratio of 138.01. The firm has a market cap of C$14.77 million, a PE ratio of -1.31 and a beta of 2.26.
About LexaGene
LexaGene Holdings Inc, a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets.
Featured Stories
- Five stocks we like better than LexaGene
- Manufacturing Stocks Investing
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- What is a support level?
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Top Nuclear Stocks Thriving on Soaring Energy Demand
Receive News & Ratings for LexaGene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LexaGene and related companies with MarketBeat.com's FREE daily email newsletter.
